Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Retail & consumer

Else Nutrition completes full-scale commercial trial manufacturing run of ready-to-drink liquid version of its Plant-Based Complete Nutrition for Toddlers and Kids

“This key milestone sets the Company on a path to penetrate the lucrative liquid format in both the Toddler and Kids Nutrition space,” said Hamutal Yitzhak, CEO and co-founder of Else Nutrition

Else Nutrition Holdings Inc (OTCQX:BABYF, TSX-V:BABY). has announced that after months of R&D and trials, it has successfully completed a full-scale commercial trial manufacturing run of ready-to-drink (RTD) liquid version of its Plant-Based Complete Nutrition for Toddlers and Kids products.

“This key milestone sets the Company on a path to penetrate the lucrative liquid format in both the Toddler and Kids Nutrition space,” said Hamutal Yitzhak, CEO and co-founder of Else Nutrition in a statement.

READ: Else Nutrition kicks off clinical study to validate growth benefits of its plant-based nutrition

“With thousands of families nationwide already using Else products in powder format, being able to offer Clean Label, whole-food-based Else products in convenient RTD form, opens up a further 92% of the Kids nutritional drinks market, a $1 billion category in the US alone," Yitzhak added.

Else said it intends to further use this capability to drive growth in the Kids and Toddler RTD markets across many geographies and sets the stage for being able to offer its planned infant formula in liquid format, upon receipt of FDA approval.

The capacity to offer Else products in liquid format further enables the brand to penetrate hospitals with a long-awaited, Plant-Based liquid formula alternative, therein creating a critical competitive advantage for the Else brand. The hospital channel is of paramount importance in a parent/caregivers’ decision-making process when it comes choosing a formula for their baby/child, it added.

On July 29, Else announced the launch of a clinical study with the Children's Hospital Colorado and University of Colorado Denver School of Medicine to validate its toddler and kids products support growth benefits in healthy young children as compared with cow-milk-based formula.

The company said the study is part of its overall efforts to establish the scientific basis for the safety and tolerance of Else Nutrition products.

Else Nutrition has the first-mover advantage with its patented 100% plant-based, non-dairy, non-soy baby and toddler nutritional products.

The company’s food items are 100% organic, vegan, natural and gluten-free, about 92% of which is made from three plants: almonds, buckwheat, and tapioca. Its products are sold under the brand name Complete Nutrition for Toddlers.

Contact the author at jon.hopkins@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK